BXMPY (Beximco Pharmaceuticals) Other Current Liabilities: $11.28 Mil (As of Mar. 2026)


What is Beximco Pharmaceuticals Other Current Liabilities?

Beximco Pharmaceuticals BXMPY 93 Other Current Liabilities is $11.28 Mil as of Mar. 2026. GuruFocus rates BXMPY with a GF Score™ of 93/100. The stock has 5 warning signs investors should review.

Beximco Pharmaceuticals's other current liabilities for the quarter that ended in Mar. 2026 was $11.28 Mil.

Beximco Pharmaceuticals's quarterly other current liabilities increased from Sep. 2025 ($10.32 Mil) to Dec. 2025 ($11.86 Mil) but then declined from Dec. 2025 ($11.86 Mil) to Mar. 2026 ($11.28 Mil).

Beximco Pharmaceuticals's annual other current liabilities increased from Jun. 2023 ($22.08 Mil) to Jun. 2024 ($23.55 Mil) but then declined from Jun. 2024 ($23.55 Mil) to Jun. 2025 ($17.71 Mil).

Beximco Pharmaceuticals Other Current Liabilities Related Terms

Beximco Pharmaceuticals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Beximco Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beximco Pharmaceuticals Other Current Liabilities Chart

Beximco Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.90 17.41 22.08 23.55 17.71

Beximco Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 17.71 10.32 11.86 11.28

Beximco Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $11.28 Mil mean?
Beximco Pharmaceuticals (BXMPY) has a Other Current Liabilities of $11.28 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Beximco Pharmaceuticals.
Is Beximco Pharmaceuticals' Other Current Liabilities too high?
Beximco Pharmaceuticals' current Other Current Liabilities is $11.28 Mil. Overall, Beximco Pharmaceuticals has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Beximco Pharmaceuticals' Other Current Liabilities compare to ZTS and UTHR?
Beximco Pharmaceuticals' Other Current Liabilities of $11.28 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Beximco Pharmaceuticals. Beximco Pharmaceuticals's current Other Current Liabilities is $11.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beximco Pharmaceuticals stock overvalued right now?
Beximco Pharmaceuticals (BXMPY) has a current Other Current Liabilities of $11.28 Mil. The current Other Current Liabilities is $11.28 Mil. Beximco Pharmaceuticals' overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Beximco Pharmaceuticals (BXMPY), the current Other Current Liabilities is $11.28 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beximco Pharmaceuticals Business Description

Address 19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.